000 | 01406 a2200373 4500 | ||
---|---|---|---|
005 | 20250512014923.0 | ||
264 | 0 | _c19890720 | |
008 | 198907s 0 0 eng d | ||
022 | _a0006-2952 | ||
024 | 7 |
_a10.1016/0006-2952(89)90422-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLagarde, M | |
245 | 0 | 0 |
_aFurther studies on the anti-thromboxane A2 activity of monohydroxylated fatty acids. _h[electronic resource] |
260 |
_bBiochemical pharmacology _cJun 1989 |
||
300 |
_a1863-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxy Acids _xpharmacology |
650 | 0 | 4 |
_aHydroxyeicosatetraenoic Acids _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 |
_aProstaglandin Endoperoxides, Synthetic _xpharmacology |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aThromboxane A2 _xantagonists & inhibitors |
700 | 1 | _aBoutillon, M M | |
700 | 1 | _aGuichardant, M | |
700 | 1 | _aLellouche, J P | |
700 | 1 | _aBeaucourt, J P | |
700 | 1 | _aVanhove, A | |
700 | 1 | _aGrée, R | |
773 | 0 |
_tBiochemical pharmacology _gvol. 38 _gno. 11 _gp. 1863-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-2952(89)90422-x _zAvailable from publisher's website |
999 |
_c2741817 _d2741817 |